These necklace and bracelet closures go beyond the utilitarian. By Sarah Royce-Greensill Reporting from London When the British jewelry designer Hannah Martin was a student at Central Saint Martins in ...
Morse Watchmans, the industry pioneer in key control and asset management systems, is highlighting its flagship KeyWatcher Touch and full suite of electronic key and asset management solutions at GSX ...
Morse Watchmans, the industry pioneer in key control and asset management systems, invites Apartmentalize 2025 attendees to visit booth #3000 June 11-13 to experience live demonstrations of the ...
For such a small task, putting on a necklace or bracelet by yourself takes an immense level of coordination. You have to be able to grasp the tiny clasp, reach behind you and find the ring to fasten ...
LONDON, England—Two-year results from the CLASP IID randomized trial and registry confirm the early benefits of transcatheter edge-to-edge repair (TEER) with the Pascal system (Edwards Lifesciences) ...
CAMBRIDGE, MA. & ROCKVILLE, MD.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation TCEs, today announced new data ...
Completing the Ressitance's Role Model Codex quest is easier said than done, but this guide is here to help players do just that. This purple item can be obtained through a few different methods, much ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Clasp founder and CEO Tess Michaels joins Wealth! to discuss her mission of connecting students with employers who will invest in their education and careers. "I actually founded Clasp from a ...
A new immuno-oncology biotech has emerged, clasping $150 million that will go toward developing next-generation T cell engagers (TCEs) targeting a range of hard-to-treat tumors. Clasp Therapeutics ...
Robert Ross had thought he would take more time off after his previous company, Surface Oncology, was acquired in September. The immuno-oncology firm had just managed to weather the stormy public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results